EPIGNOSTIX
LIVE

Serial Number

79434826

Owner

Heidelberg Epignostix GmbH

Attorney

Brittany Kaur Singh

Filing Date

Aug 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EPIGNOSTIX Trademark

Serial Number: 79434826

EPIGNOSTIX is a trademark filed by Heidelberg Epignostix GmbH on August 12, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Heidelberg Epignostix GmbH (3 trademarks)

c/o BioLabs Heidelberg,

Entity Type: 27

Trademark Details

Filing Date

August 12, 2025

Registration Date

Not Registered

Published for Opposition

August 4, 2026

Goods & Services

Providing cancer screening testing services; medical analysis services for the diagnosis of cancer; genetic testing for cancer risk for medical purposes; medical analysis services for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis, namely analysis services using software; performing RNA and DNA analyses for the diagnosis and prognosis of cancer; medical services in the field of oncology.

Scientific research for medical purposes in the area of cancerous diseases; software as a service (SaaS) services, namely, hosting software for use by others for classification and diagnosis of digital DNA or of epigenetic data and rental of software for use in classification and diagnosis of digital DNA or of epigenetic data ; software as a service (SaaS) services, namely, hosting software for use by others for classification and diagnosis of digital DNA or of epigenetic data in the field of oncology and rental of software for classification and diagnosis of digital DNA or of epigenetic data in the area of oncology; software as a service (SaaS) services, namely, hosting software for use by others for classification and diagnosis of digital DNA or of epigenetic data in the medical field and rental of software for classification and diagnosis of digital DNA or of epigenetic data in the medical field; software as a service (SaaS) services, namely, hosting software for use by others for tumor diagnosis and rental of software for tumor diagnosis; software as a service (SaaS) services, namely, hosting software for use by others for DNA analysis and rental of software for DNA analysis; software as a service (SaaS) services, namely, hosting software for use by others for the analysis of cancer and rental of software for the analysis of cancer; software development, programming and implementation; updating of memory bank software of computer systems; design and development of electronic databases software; development and testing of computing methods, algorithms and software; medical research in the field of oncology; testing, namely, product safety testing; quality control; testing, authentication, and quality control, namely quality control of hosting services, software as a service (SaaS), and software rental; quality control of hosting services, software as a service (SaaS), and software rental, namely of the aforementioned software as a service (SaaS); medical research laboratory services, namely, classification in the field of oncology; medical research laboratory services, namely, classification of tumors and cancer

Downloadable and recorded electronic data files featuring genetic and epigenetic data; Downloadable and recorded software for recording, storage, transmission or reproduction of genetic and epigenetic data content; downloadable and recorded application software for classification and diagnosis of downloadable and recorded digital DNA and epigenetic data and downloadable and recorded file management and database software for creating and managing image and data files representing classification and diagnosis of downloadable and recorded digital DNA and epigenetic data; downloadable and recorded database management software for genetic and epigenetic data; downloadable and recorded file server operating software for use in the field of genetic and epigenetic data; downloadable and recorded artificial intelligence software for classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded artificial intelligence software for analyses of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded artificial intelligence software for analyses, namely, analyses in the field of tumor diagnostics; downloadable and recorded artificial intelligence software for healthcare for classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded artificial intelligence software for file sharing in the field of genetic and epigenetic data; downloadable and recorded software for data and file management and for databases for creating and managing image and data files of the classification result of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded software for searching and retrieving information across a computer network in the field of genetic and epigenetic data; downloadable and recorded data software for monitoring health using genetic and epigenetic data; downloadable and recorded software for recording training data in the field of classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded software for recording training data, namely, genetic and epigenetic training data in the field of oncology; downloadable and recorded software for recording training data, namely, genetic and epigenetic training data in the field of tumor diagnostics; downloadable and recorded data software for recording training data, namely, genetic and epigenetic training data in the field of genetics; downloadable and recorded software for recording training data, namely, genetic and epigenetic training data comprising nucleic acid data, DNA data and biochemical data; downloadable and recorded software for integrating of artificial intelligence and machine learning in the field of big data in the field of genetic and epigenetic data; downloadable and recorded software for healthcare, namely, for healthcare in the field of oncology for classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded software for machine learning for creating data models classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded software for machine learning for analysis of genetic and epigenetic data from patient samples of blood or tissue; downloadable and recorded software for machine learning for analysis purposes, namely, analysis in the field of tumor diagnostics using genetic and epigenetic data; downloadable and recorded interactive software based on artificial intelligence for classification and diagnosis of patient samples of blood or tissue using genetic and epigenetic data; downloadable and recorded software for integrating artificial intelligence and machine learning in the field of big data in the field of genetic and epigenetic data; downloadable software as a medical device (SaMD) for treating oncological diseases; downloadable software as a medical device(SaMD), namely, for the classification of tumors; downloadable software as a medical device(SaMD), namely, for the automated analysis of tumors; downloadable software as a medical device (SaMD), namely, for medical diagnostics for treating oncological diseases; downloadable software as a medical device(SaMD), namely, for tumor diagnostics; downloadable software as a medical device (SaMD), namely, in the field of oncology for classification and diagnosis of patient samples of blood or tissue

Diagnostic, examination, and monitoring equipment for medical purposes, namely, equipment for DNA analysis, for analysis of genetic sequences, and for epigenetic analysis; diagnostic apparatus for medical purposes, namely, diagnostic genetic and epigenetic apparatus for medical purposes; diagnostic apparatus for medical purposes, namely, for diagnosing tumors; automatic analyzers for medical diagnostics, namely, for genetic and epigenetic medical diagnostics; automatic analyzers for medical diagnostics, namely, for automated analysis of tumors; automatic analyzers for medical diagnostics, namely, for automated analysis of patient blood, tissue and DNA samples; automatic analysis apparatus for medical diagnosis, namely, for automated analysis of DNA; diagnostic apparatus for medical purposes used in medical laboratories, namely, diagnostic genetic and epigenetic apparatus for medical purposes; apparatus for tumor diagnosis

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 6, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 6, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2026 CNEA
LIMITATION OF GOODS RECEIVED FROM IB
May 21, 2026 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 30, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 30, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 16, 2025 REPR